chr1-201077915-C-T
Variant summary
The NM_000069.3(CACNA1S):c.1583G>A (p.Arg528His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00000372 (AC=6) in the gnomAD database across 1,613,896 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000147. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.87). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV001445907: Functional studies have demonstrated that this variant alters the electrophysiological properties of the calcium channel, including potassium-dependent paradoxical membrane depolarization (PMID:8605978, 9512357, 19225109), and a mouse model of this variant recapitulates the essential features of hypokalemic periodic paralysis in humans, including muscle weakness (PMID:23187123)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R528C: Pathogenic/Likely_pathogenic (ClinVar VariationId 849085, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R528S: Uncertain_significance (ClinVar VariationId 4689585, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance, associated with Hypokalemic periodic paralysis, type 1 (hokpp1); it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000069.3 missense
Scores
Clinical Significance
Conservation
Publications
- hypokalemic periodic paralysis, type 1Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- malignant hyperthermia, susceptibility to, 5Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- congenital myopathyInheritance: AR, SD, AD Classification: STRONG Submitted by: Genomics England PanelApp, Illumina
- congenital myopathy 18Inheritance: AR, AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hypokalemic periodic paralysisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 2 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000015 — very rare (O3 supporting [+1]) | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000069.3. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CACNA1S | TSL:1MANE Select | c.1583G>A p.Arg528His | missense | Exon 11 of 44 | Prot: ENSP00000355192.3 UniProt: | |
CACNA1S | TSL:5 | c.1583G>A p.Arg528His | missense | Exon 11 of 43 | Prot: ENSP00000356307.3 UniProt: | |
CACNA1S | c.1583G>A p.Arg528His | missense | Exon 11 of 43 | Prot: ENSP00000505162.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 5 sources | |||||
GnomAD3 genomes | AF: 0.00000657 | AC:1 | Hom:0 | AN:152214 | Cov:33 |
GnomAD4 exome | AF: 0.00000342 | AC:5 | Hom:0 | AN:1461682 | Cov:30 |
GnomAD4 genome | AF: 0.00000657 | AC:1 | Hom:0 | AN:152214 | Cov:33 |
TOPMed (Bravo) | AF: 0.00000378 | AC:1 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000485 | AC:11 | Hom:0 | AN:226764 | |
Local & regional cohorts 1 source | |||||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.00000800 | AC:1 | Hom:0 | AN:122660 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.000208 * | 2 | 9622 | 0.00 * | 0 | 10428 |
SCHEMA | 0.00 | 0 | 77642 | 0.00000718 | 1 | 139308 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 27 | |
AlphaMissense | Pathogenic | 0.88 | |
BayesDel_addAF | Pathogenic | 0.56 | D |
BayesDel_noAF | Pathogenic | 0.56 | |
CADD | Pathogenic | 32 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Pathogenic | 0.87 | D |
Eigen | Pathogenic | 1.1 | |
Eigen_PC | Pathogenic | 0.91 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
GPN-Star LLR | N/A | -8.1 | |
GPN-Star score | N/A | 8.1 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Uncertain | 0.13 | D |
MetaRNN | Pathogenic | 0.96 | D |
MetaSVM | Pathogenic | 0.99 | D |
Mutation Taster | N/A | 10/90 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 4.3 | H |
PhyloP100 | Pathogenic | 7.9 | |
popEVE | Benign | -3.7 | |
PrimateAI | Pathogenic | 0.79 | T |
PROVEAN | Pathogenic | -4.7 | D |
REVEL | Pathogenic | 0.96 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.93 | |
VESM-3B | Benign | -13 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.010 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.